If you think you may have symptoms of coronavirus (opens in new window) >, follow the national guidance and self-isolate for 10 days. Please see our information for visitors > before you plan on visiting one of our hospitals. If you, or a member of your family has tested positive for coronavirus, please find resources to aid your/their recovery on our supporting your recovery from coronavirus > page.
Magnetic resonance imaging (MRI) allows us to see inside the human body in amazing detail. However, when it comes to the kidneys, MRI is not routinely used in clinical practice.
MRI can measure different processes that can cause kidney disease, including altered tissue microstructure (inflammation/fibrosis), oxygenation and perfusion.
Research is needed to work out how these MRI techniques can help people suffering from kidney disease. To address this, the AFiRM study has been designed and developed by a team of researchers from across the UK.
The AFiRM study will use MRI to determine the severity and nature of kidney disease in 450 people, and then use these to track changes over time. By doing so, we hope to show how kidney MRI can improve the way that patients with kidney disease are assessed, which ultimately may allow better, more individualised treatments.
We offer a bespoke service to investigators, sponsors and industry partners, through the design, delivery, analysis and reporting of high quality clinical research.
Derby Clinical Trials Support Unit (Derby CTSU)